共 50 条
- [4] Basal-Bolus Insulin Regimen for Hospitalised Patients with COVID-19 and Diabetes Mellitus: A Practical Approach Diabetes Therapy, 2020, 11 : 2177 - 2194
- [9] Insulin degludec improves glycaemic control with lower nocturnal hypoglycaemia risk than insulin glargine in basal-bolus treatment with mealtime insulin aspart in Type 1 diabetes (BEGIN® Basal-Bolus Type 1): 2-year results of a randomized clinical trial DIABETIC MEDICINE, 2013, 30 (11) : 1293 - 1297